Clinical management of pyoderma gangrenosum

American Journal of Clinical Dermatology

Volumn 3, Issue 3, 2002, Pages 149-158

  Wollina, Uwe ^a  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZATHIOPRINE; CHLORAMBUCIL; CLOFAZIMINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; DAPSONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; METHOTREXATE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINE; SULFANILAMIDE DERIVATIVE; THALIDOMIDE;

CELL TRANSPLANTATION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; ENTERITIS; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATINOCYTE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PYODERMA GANGRENOSUM; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHEUMATIC DISEASE; SKIN MANIFESTATION; SPLIT THICKNESS SKIN GRAFT; SUPERINFECTION; WOUND DRESSING;

EID: 0036091370     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200203030-00002     Document Type: Review

References (78)

1. Pyoderma (ecthyma) gangrenosum: Clinical and experimental observations in five cases occuring in adults
2. Darstellung des pyoderma gangraenosum in einem dermatologischen atlas des frühen 19: Jahrhunderts
3. Pyoderma gangrenosum
4. Pyoderma gangrenosum: A report of 44 cases with follow-up
5. Pyoderma gangrenosum in infants and children
6. Pyoderma gangrenosum in infancy
7. Pyoderma gangrenosum at surgery sites
8. Histopathologic and immunopathologic study of pyoderma gangrenosum
9. Aberrant integrin (CR4; αxβ2; CD11c/CD18) oscillation on neutrophils in a mild form of pyoderma gangrenosum
10. Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum
11. Elafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: Interleukin-1 beta and tumour necrosis factor-alpha stimulate ist secretion in vitro
12. Identification of mesoderm development (mesd) candidate genes: Comparative mapping and genome sequence analysis
13. Pyoderma gangrenosum: A review
14. Pyostomatitis vegetans: A reactive mucosal marker for inflammatory disease of the gut
15. Multiple aseptic pulmonary nodules with central necrosis in a patient with pyoderma gangrenosum
16. Neutrophilic myositis as an extracutaneous manifestation of neutrophilic dermatosis
17. Present status of pyoderma gangrenosum
18. Pyoderma gangrenosum: Classification and management
19. The evolution of pyoderma gangrenosum: A clinico-pathologic correlation
20. Histopathologic features of superficial granulomatous pyoderma gangrenosum
21. Granulomatous pyoderma gangrenosum: Two unusual cases showing necrotizing granulomatous inflammation
22. Pyoderma gangrenosum: A comparison of typical and atypical cases with an emphasis on time to remission, case review of 86 patients of 2 institutions
23. Sweet's syndrome: Pyoderma gangrenosum and acute leukaemia
24. The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study
25. TenderWet: An innovation in moist wound healing
26. Synthetic dressings
27. Moderne wunddressings: Ein update
28. Topical treatment of malignant wounds
29. Explanttest mit haut und peritoneum der neonatalen ratte als prädiktiver toleranztest für lokale anti-infektiöse substanzen für wunden und körperkavitäten
30. Contact allergy associated with topical treatment
31. A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers
32. Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix
33. Intralesional steroid therapy of pyoderma gangrenosum
34. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK-506)
35. Topical tacrolimus for pyoderma gangrenosum
36. Pyoderma gangraenosum: Erfolgreiche topische therapie mit tacrolimus (FK506)
37. Parastomal pyoderma gangrenosum: Clinical features and management
38. Erfolgreiche topische anwendung von cyclosporin A bei pyoderma gangraenosum
39. Clearing of pyoderma gangrenosum by intralesional cyclosporin A
40. Effectiveness of 4% disodium chromoglycate in the treatment of pyoderma gangrenosum
41. Treatment of pyoderma gangrenosum with 4% cromolyn
42. The benefits of smoking in skin disease
43. Successful treatment of pyoderma gangrenosum with nicotine chewing gum
44. Recombinant human GM-CSF in the treatment of poorly healing wounds
45. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment
46. Topical sucralfate in the management of peristomal skin disease: An open study
47. Pulse therapy: Therapeutic efficacy in the treatment of pyoderma gangrenosum
48. Treatment of pyoderma gangrenosum with cyclosporine
49. Cyclosporin treatment of pyoderma gangrenosum
50. Niedrig dosierte cyclosporin-A-therapie bei pyoderma gangraenosum: Erfahrungen bei 6 patienten
51. Pyoderma gangrenosum and related disorders
52. Clofazimine: A review of its medical uses and mechanisms of action
53. Potential novel uses of thalidomide: Focus on palliative care
54. Therapieresistentes pyoderma gangraenosum: Eine behandlung mit mycophenolatmofetil und cyclosporinA
55. Treatment of pyoderma gangrenosum with methotrexate
56. Pyoderma gangrenosum: Response to cyclophosphamide therapy
57. Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum
58. Intravenous immunoglobulin therapy in dermatology; review and center experience
59. Efficacy of human immune globulin in pyoderma gangrenosum
60. Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin
61. Pyoderma gangrenosum in a patient with cryoglobulinemia and hepatitis C successfully treated with interferon alfa
62. Plasmapheresis and cyclophosphamide as successful treatments for pyoderma gangrenosum
63. Treatment of pyoderma gangrenosum with colchicine
64. Pyoderma gangrenosum treated with hyperbaric oxygen therapy
65. Improvement of pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody
66. Pyoderma gangrenosum following breast reconstruction
67. Pyoderma gangrenosum induced by acupuncture in a patient with ulcerative colitis
68. Pyoderma gangrenosum of the breast: Sequential grafting
69. Split skin grafts in the treatment of pyoderma gangrenosum: A report of four cases
70. Management of vasculitic leg ulcers and pyoderma gangrenosum
71. Surgical management of pyoderma gangrenosum: Case report and review
72. Biologic skin substitutes
73. Keratinocyte grafting; a new means of transplantation for full thickness wounds
74. Successful treatment of chronic leg ulcers with epidermal equivalents generated from cultured autologous outer root sheath cells
75. The use of cultured epithelial autograft in a patient with idiopathic pyoderma gangrenosum
76. Treatment of pyoderma gangrenosum with cultured keratinocyte autografts
77. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression
78. Management strategies for pyoderma gangrenosum: Case studies and review of the literature